Fri.Nov 24, 2023

article thumbnail

Bayer expands German manufacturing facilities to fulfill supply demand

Pharmaceutical Technology

Bayer announced the launch of a Berlin, Germany-based manufacturing facility to meet future demands from the US, China and Europe.

article thumbnail

NHS urges individuals to take up cervical screening invitations

Pharma Times

Around 3,200 new cases of cervical cancer are diagnosed in the UK every year - News - PharmaTimes

141
141
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

F. Hoffmann-La Roche sees highest patent filings and grants during August in Q3 2023

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for F. Hoffmann-La Roche here.

147
147
article thumbnail

Study suggests cognitive decline could be linked to hippocampus shrinkage

Pharma Times

The findings could benefit patients living with neurodegenerative conditions - News - PharmaTimes

133
133
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Johnson & Johnson sees highest patent filings and grants during August in Q3 2023

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Johnson & Johnson here.

147
147
article thumbnail

How to optimise commercial-scale ATMP manufacturing through automation

pharmaphorum

How to optimise commercial-scale ATMP manufacturing through automation Mike.

More Trending

article thumbnail

International Health Partners' Christmas campaign: Working with pharma for patients worldwide

pharmaphorum

International Health Partners' Christmas campaign: Working with pharma for patients worldwide Nicole.

101
101
article thumbnail

Novartis sees highest patent filings and grants during August in Q3 2023

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Novartis here.

147
147
article thumbnail

Calliditas Therapeutics' partner Everest Medicines' announces kidney drug approval

Outsourcing Pharma

Calliditas Therapeutics AB announced today (November 24) that its partner Everest Medicines has revealed that China's National Medical Products Administration (NMPA) has approved Nefecon.

article thumbnail

Bristol-Myers Squibb sees highest patent filings and grants during August in Q3 2023

Pharmaceutical Technology

Access and buy GlobalData’s databook on the latest filings and grants activity for Bristol-Myers Squibb here.

147
147
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Progress for Johnson & Johnson's lung cancer drug as extension submitted to EMA

Outsourcing Pharma

The Janssen Pharmaceutical Companies of Johnson & Johnson announced last week (November 23) the submission of a type 2 extension of indication application to the European Medicines Agency (EMA).

article thumbnail

Sosei to regain rights to IBD drug after GSK discontinues programme

Pharmaceutical Technology

The Sosei Heptares oral IBD drug was first licensed to GSK in 2020 and is currently in Phase I clinical development.

Licensing 147
article thumbnail

Postum: A Time-Honored Coffee Alternative

XTalks

In the world of hot beverages, Postum occupies a unique place. Originating as a coffee alternative, this drink has carved out a niche among those seeking a caffeine-free option. To understand its enduring appeal, let’s delve into its history, ingredients and its status in today’s beverage market. The Birth of Postum Postum was born out of necessity.

article thumbnail

Vertex obtains EC approval for combination therapy to treat CF

Pharmaceutical Technology

Vertex Pharmaceuticals has obtained approval from EC) for the label expansion of Kaftrio plus ivacaftor to treat children with CF.

147
147
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Which pharmaceutical drugs have the most drug patents in Croatia?

Drug Patent Watch

This chart shows the drugs with the most patents in Croatia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… The post Which pharmaceutical drugs have the most drug patents in Croatia? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59
article thumbnail

Novo Nordisk expands site to manufacture GLP-1 drugs

Pharmaceutical Technology

The expansion comes as Novo is trying to maintain strong growth in T2D after the launch of Eli Lilly’s Zepbound this month.

article thumbnail

New patent for Abbvie drug RINVOQ

Drug Patent Watch

Annual Drug Patent Expirations for RINVOQ Rinvoq is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are twenty-six patents protecting… The post New patent for Abbvie drug RINVOQ appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59
article thumbnail

China’s NMPA approves ArkBio’s RSV neutralising antibody drug

Pharmaceutical Technology

China’s NMPA has approved ArkBio IND application for its respiratory syncytial virus (RSV) neutralising antibody, AK0610.

Antibody 130
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

New patent for Antares Pharma drug XYOSTED (AUTOINJECTOR)

Drug Patent Watch

Annual Drug Patent Expirations for XYOSTED+%28AUTOINJECTOR%29 Xyosted (autoinjector) is a drug marketed by Antares Pharma Inc and is included in one NDA. It is available from one supplier. There are… The post New patent for Antares Pharma drug XYOSTED (AUTOINJECTOR) appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59
article thumbnail

Lupin introduces triple combination Vilfuro-G in India for COPD

Pharmaceutical Technology

Lupin has introduced the fixed-dose triple combination drug (FDC), Vilfuro-G, to manage chronic COPD in India.

Drugs 130
article thumbnail

NHS Confederation, ABPI say break down barriers to partnerships and change the lives of millions

pharmaphorum

NHS Confederation, ABPI say break down barriers to partnerships and change the lives of millions Nicole.

59
article thumbnail

What’s in a name: Agencies struggle to keep up with expanding drug space 

Pharmaceutical Technology

With more approved drugs coming through than ever before, the need to avoid confusing names to ensure patient safety is important.

Drugs 130
article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Intellectual property: Striking the balance

pharmaphorum

Intellectual property: Striking the balance Mike.

59
article thumbnail

Ellipses receives orphan drug designation for selective RET inhibitor

Pharmaceutical Technology

Ellipses Pharma has secured ODD from the US FDA for its next generation EP0031/A400, to potentially treat solid tumours.

Drugs 130
article thumbnail

Progress for Johnson & Johnson's lung cancer drug as extension submitted to EMA

Outsourcing Pharma

The Janssen Pharmaceutical Companies of Johnson & Johnson announced last week (November 23) the submission of a type 2 extension of indication application to the European Medicines Agency (EMA).

article thumbnail

Health Canada approves Jazz’s cannabis derived seizure therapy

Pharmaceutical Technology

Epidiolex has been approved as an adjunct therapy for seizures associated with three rare forms of epilepsy in patients aged two and older.

328
328
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud